FXAIX
Price
$224.39
Change
+$1.14 (+0.51%)
Updated
Sep 3 closing price
Net Assets
696.27B
RICFX
Price
$65.25
Change
+$0.16 (+0.25%)
Updated
Sep 3 closing price
Net Assets
171.53B
Interact to see
Advertisement

FXAIX vs RICFX

Header iconFXAIX vs RICFX Comparison
Open Charts FXAIX vs RICFXBanner chart's image
Fidelity 500 Index
Price$224.39
Change+$1.14 (+0.51%)
VolumeN/A
Net Assets696.27B
American Funds Invmt Co of Amer R5
Price$65.25
Change+$0.16 (+0.25%)
VolumeN/A
Net Assets171.53B
FXAIX vs RICFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FXAIX vs. RICFX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and RICFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 696B vs. RICFX (172B). FXAIX pays higher dividends than RICFX: FXAIX (1.16) vs RICFX (1.09). FXAIX was incepted earlier than RICFX: FXAIX (14 years) vs RICFX (23 years). RICFX (0.31) is less costly to investors than FXAIX (0.01). RICFX is a more actively managed with annual turnover of: 32.00 vs. FXAIX (2.00). FXAIX has a lower initial minimum investment than RICFX: FXAIX (0) vs RICFX (250). FXAIX annual gain was more profitable for investors over the last year : 17.55 vs. RICFX (13.26). FXAIX return over 5 years is better than : 101.58 vs. RICFX (68.02).
FXAIXRICFXFXAIX / RICFX
Total Expense Ratio0.010.315%
Annual Report Gross Expense Ratio0.010.315%
Fund Existence14 years23 years-
Gain YTD10.01213.88172%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets696B172B405%
Annual Yield % from dividends1.161.09107%
Returns for 1 year17.5513.26132%
Returns for 3 years70.8661.36115%
Returns for 5 years101.5868.02149%
Returns for 10 years266.28100.27266%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BDRX5.690.33
+6.16%
Biodexa Pharmaceuticals plc
CNTX0.85N/A
+0.02%
Context Therapeutics
WOW5.08N/A
N/A
WideOpenWest
MBLY13.70-0.03
-0.22%
Mobileye Global
RXRX4.63-0.03
-0.64%
Recursion Pharmaceuticals